Alcista
$96.20
Precio del escenario
$80.220
-1.749 (-2.18%)Al cierre
SS&C Technologies Holdings, Inc. is a provider of services and software for the financial services and healthcare industries. Its portfolio of products and software-enabled services allows our financial services clients to automate and integrate front-office functions such as trading and modeling, middle-office functions such as portfolio management and reporting, and back-office functions such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting. The Company provides its solutions within the institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory and financial institutions vertical markets. It provides solutions to the healthcare industry, including pharmacy, healthcare administration and health outcomes optimization solutions. Its healthcare solutions include claims adjudication, benefit management, care management and business intelligence services.
SS&C Technologies Holdings Inc is currently not a strong buy due to its recent price drop and technical indicators, but it shows potential for recovery. The current price is $82.96, which is below the Fibonacci Pivot level of $84.968, indicating a resistance point. The RSI is at 43.579, suggesting it is nearing oversold territory, which could lead to a rebound. However, the stock has seen a 7.35% decline following its latest earnings report, which missed estimates slightly, indicating potential short-term volatility. The forward P/E ratio of 10.6157 suggests it is undervalued compared to its growth prospects, but caution is warranted due to the recent performance and market conditions.
RBC Capital
$101
2026-08-31
RBC Capital
2026-08-31
Precio objetivo
$101
RBC Capital
$92
2026-07-24
RBC Capital
2026-07-24
Precio objetivo
$92
Jefferies
$83
2026-07-20
Jefferies
2026-07-20
Precio objetivo
$83
JPMorgan
$87
2026-07-20
JPMorgan
2026-07-20
Precio objetivo
$87
Morgan Stanley
$78
2026-04-24
Morgan Stanley
2026-04-24
Precio objetivo
$78
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
SS&C Tech Raises 2026 Full-Year Guidance Amid Strong Cash Flow

Principal Real Estate Fund Announces Management Changes

Energy Stocks Surge as Oil Prices Exceed $100 Amid Middle East Tensions

SS&C Releases 2026 PE Dealmaking Report

SS&C Releases Survey Findings on AI Implementation
SS&C Technologies Holdings, Inc. is a provider of services and software for the financial services and healthcare industries. Its portfolio of products and software-enabled services allows our financial services clients to automate and integrate front-office functions such as trading and modeling, middle-office functions such as portfolio management and reporting, and back-office functions such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting. The Company provides its solutions within the institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory and financial institutions vertical markets. It provides solutions to the healthcare industry, including pharmacy, healthcare administration and health outcomes optimization solutions. Its healthcare solutions include claims adjudication, benefit management, care management and business intelligence services. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
SS&C Technologies Holdings Inc is currently not a strong buy due to its recent price drop and technical indicators, but it shows potential for recovery. The current price is $82.96, which is below the Fibonacci Pivot level of $84.968, indicating a resistance point. The RSI is at 43.579, suggesting it is nearing oversold territory, which could lead to a rebound. However, the stock has seen a 7.35% decline following its latest earnings report, which missed estimates slightly, indicating potential short-term volatility. The forward P/E ratio of 10.6157 suggests it is undervalued compared to its growth prospects, but caution is warranted due to the recent performance and market conditions.
12 analysts cover SSNC: 11 rate it Buy, 1 Hold and 0 Sell. The average price target is 103.29.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.